NFA
ATRS

Nationwide Fund Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Nationwide Fund Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-80,791
Closed -$262K – 2474
2017
Q3 		$262K Hold
80,791
– – ﹤0.01% 2506
2017
Q2 		$260K Buy
+80,791
New +$229K ﹤0.01% 2514
2016
Q2 		– Sell
-105,808
Closed -$92K – 3323
2016
Q1 		$92K Buy
105,808
+5,626
+6% +$5.44K ﹤0.01% 2856
2015
Q4 		$121K Hold
100,182
– – ﹤0.01% 2773
2015
Q3 		$170K Hold
100,182
– – ﹤0.01% 2651
2015
Q2 		$208K Buy
100,182
+15,380
+18% +$37.3K ﹤0.01% 2693
2015
Q1 		$230K Sell
84,802
-4,672
-5% -$11.9K ﹤0.01% 2622
2014
Q4 		$230K Sell
89,474
-1,007
-1% -$2.26K ﹤0.01% 2554
2014
Q3 		$166K Buy
90,481
+1,274
+1% +$2.78K ﹤0.01% 2788
2014
Q2 		$238K Buy
+89,207
New +$268K ﹤0.01% 2660
2014
Q1 		– Sell
-87,026
Closed -$390K – 3228
2013
Q4 		$390K Sell
87,026
-2,711
-3% -$11K ﹤0.01% 2356
2013
Q3 		$364K Buy
89,737
+6,948
+8% +$30.3K ﹤0.01% 2377
2013
Q2 		$344K Buy
+82,789
New +$320K ﹤0.01% 2220

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nationwide Fund Advisors's ATRS Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Antares Pharma, Inc. (ATRS) in Q4 2017, closing a stake of 80,791 shares — an estimated $262K sold.

Nationwide Fund Advisors first reported a position in ATRS in Q2 2013 and held it in 13 quarters. The position peaked at $390K in Q4 2013. 110 funds tracked by Wall St. Rank hold ATRS as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Antares Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 80,791 Antares Pharma, Inc. shares in Q4 2017, an estimated $262K.
  • Nationwide Fund Advisors first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 13 quarters.
  • Nationwide Fund Advisors's Antares Pharma, Inc. position peaked at $390K in Q4 2013.
  • 110 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.